Indian equity markets showed mixed performance on March 19, 2026, with selective pressure persisting in several counters. Over 50 stocks touched fresh 52-week lows amid ongoing profit booking and stock-specific weakness, even as broader indices traded with caution.
The list featured a mix of large-cap, mid-cap, and small-cap names, highlighting continued underperformance in select sectors.
Notable Stocks at 52-Week Lows (Selected by Impact & Name Recognition):
| Symbol | Series | LTP | % Chng | New 52W Low | Prev Low | Prev Date |
|---|---|---|---|---|---|---|
| CIPLA | EQ | 1256.80 | -0.92 | 1243.80 | 1264.60 | 18-Mar-2026 |
| PGHH | EQ | 9944.00 | -0.75 | 9908.00 | 9958.00 | 17-Mar-2026 |
| BATAINDIA | EQ | 658.85 | -2.12 | 653.25 | 665.10 | 17-Mar-2026 |
| COLPAL | EQ | 1919.80 | -1.12 | 1911.30 | 1919.00 | 16-Mar-2026 |
| SANOFI | EQ | 3436.00 | -0.72 | 3396.00 | 3415.00 | 16-Mar-2026 |
| CRISIL | EQ | 3993.20 | -1.00 | 3950.00 | 3973.60 | 07-Apr-2025 |
| SBICARD | EQ | 694.20 | -2.98 | 686.30 | 687.80 | 17-Mar-2026 |
| RELINFRA | BE | 77.80 | -1.83 | 76.00 | 76.55 | 18-Mar-2026 |
| UNIDT | EQ | 155.43 | -4.57 | 152.20 | 160.61 | 18-Mar-2026 |
| OSIAHYPER | EQ | 5.25 | -4.89 | 5.25 | 5.52 | 18-Mar-2026 |
| RNBDENIMS | BE | 87.74 | -4.99 | 87.74 | 92.35 | 18-Mar-2026 |
| SADBHIN | EQ | 2.77 | -2.46 | 2.70 | 2.84 | 18-Mar-2026 |
Key Highlights:
- CIPLA continued its downward drift, closing at a new 52-week low of ₹1,243.80 amid broader pharma sector caution.
- Consumer staples heavyweights PGHH (Procter & Gamble Hygiene) and COLPAL (Colgate-Palmolive) also hit fresh yearly lows.
- BATAINDIA and SANOFI reflected persistent weakness in consumer discretionary and pharma spaces.
- Small-cap and micro-cap names like OSIAHYPER, RNBDENIMS, SADBHIN, and SEL remained deeply pressured, many locking near or at lower circuits earlier in the session.
- Several stocks including RELINFRA, UNIDT, and CRISIL extended recent declines to new lows.
While frontline indices held ground with selective buying, these counters underscored ongoing rotation away from underperformers.
